Pfizer : PFE

All Pfizer Articles

1518 Articles

Jon C. Ogg | Aug 10, 2016 at 8:05 AM EDT

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

The short interest data for the July 29 settlement date are out and it almost feels like short sellers are…

Paul Ausick | Aug 8, 2016 at 4:01 PM EDT

Healthcare Stocks Sink DJIA on Monday

August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red…

Paul Ausick | Aug 8, 2016 at 7:55 AM EDT

Why Allergan Earnings Aren’t Telling the Whole Story

Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.

Paul Ausick | Aug 2, 2016 at 4:01 PM EDT

Apple, Pfizer Sink DJIA on Tuesday

August 2, 2016: Markets opened nearly flat again Tuesday on stronger oil prices early in the day before reality set…

Chris Lange | Aug 2, 2016 at 9:05 AM EDT

Pfizer Earnings Fail to Impress Investors

When Pfizer reported its second-quarter financial results before the markets opened on Tuesday, investors initially did not appear impressed.

Chris Lange | Aug 1, 2016 at 11:25 AM EDT

What to Expect From Pfizer Earnings

The upcoming earnings report will showcase what Pfizer has to offer for the second half of 2016, and potentially give…

Chris Lange | Jul 31, 2016 at 10:50 AM EDT

The Top 10 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and other major companies reporting their quarterly results…

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Lee Jackson | Jul 16, 2016 at 9:15 AM EDT

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great…

Paul Ausick | Jul 14, 2016 at 4:01 PM EDT

Goldman Sachs, Apple Boost DJIA on Thursday

July 14, 2016: Markets opened higher again Thursday after producer prices came in higher than expected for June and new…

Jon C. Ogg | Jul 14, 2016 at 8:40 AM EDT

5 Companies Likely Buying Back the Most Stock in June and July

With many stocks having just hit record highs, investors need at least a bit of an explanation here. One thing…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Douglas A. McIntyre | Jul 9, 2016 at 9:25 AM EDT

Viagra Price Drops 50% as Drug Faces Competition

Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.

Lee Jackson | Jul 5, 2016 at 10:25 AM EDT

Jefferies Makes Major Change to Franchise Picks Stock Portfolio

Solid dividend-paying stocks make sense for the rest of this year. While it looks like the stress from the Brexit…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

1 … 49 50 51 52 53 … 102

Pfizer : PFE

All Pfizer Articles

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Healthcare Stocks Sink DJIA on Monday

Why Allergan Earnings Aren’t Telling the Whole Story

Apple, Pfizer Sink DJIA on Tuesday

Pfizer Earnings Fail to Impress Investors

What to Expect From Pfizer Earnings

The Top 10 Earnings for the Week Ahead

Short Sellers Get Selective on Major Pharma

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Goldman Sachs, Apple Boost DJIA on Thursday

5 Companies Likely Buying Back the Most Stock in June and July

Short Sellers Run for Cover From Major Pharma

Viagra Price Drops 50% as Drug Faces Competition

Jefferies Makes Major Change to Franchise Picks Stock Portfolio

How Major Pharma Is Faring After the Brexit

How Safe Is CVS Health’s Dividend?

She Bought a $100 Share of a Racehorse. Then It Produced a $60,000 Windfall, and a Medicare Surprise.

While Mark Cuban Jokes About Data Centers Becoming Pickleball Courts, Kevin O’Leary’s $100 Billion Utah Project Just Got Scaled Back

She Bought a $100 Share of a Racehorse. Then It Produced a $60,000 Windfall, and a Medicare Surprise.

He Retired, Then Took the Bus-Driving Job His School District Couldn't Fill. The Social Security Earnings Test Reshapes His Paycheck.

How Safe Is CVS Health’s Dividend?

She Bought a $100 Share of a Racehorse. Then It Produced a $60,000 Windfall, and a Medicare Surprise.

Pfizer : PFE

All Pfizer Articles

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

Healthcare Stocks Sink DJIA on Monday

Why Allergan Earnings Aren’t Telling the Whole Story

Apple, Pfizer Sink DJIA on Tuesday

Pfizer Earnings Fail to Impress Investors

What to Expect From Pfizer Earnings

The Top 10 Earnings for the Week Ahead

Short Sellers Get Selective on Major Pharma

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Goldman Sachs, Apple Boost DJIA on Thursday

5 Companies Likely Buying Back the Most Stock in June and July

Short Sellers Run for Cover From Major Pharma

Viagra Price Drops 50% as Drug Faces Competition

Jefferies Makes Major Change to Franchise Picks Stock Portfolio

How Major Pharma Is Faring After the Brexit

How Safe Is CVS Health’s Dividend?

She Bought a $100 Share of a Racehorse. Then It Produced a $60,000 Windfall, and a Medicare Surprise.

While Mark Cuban Jokes About Data Centers Becoming Pickleball Courts, Kevin O’Leary’s $100 Billion Utah Project Just Got Scaled Back

Featured Reads

She Bought a $100 Share of a Racehorse. Then It Produced a $60,000 Windfall, and a Medicare Surprise.

He Retired, Then Took the Bus-Driving Job His School District Couldn't Fill. The Social Security Earnings Test Reshapes His Paycheck.